Molecular Templates (MTEM) Short Interest Ratio & Short Volume $0.37 -0.01 (-3.51%) (As of 12:30 PM ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends Molecular Templates Short Interest DataMolecular Templates (MTEM) has a short interest of 270,100 shares, representing 4.97% of the float (the number of shares available for trading by the public). This marks a 7.44% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 2.81 million shares to cover all short positions.Current Short Interest270,100 sharesPrevious Short Interest251,400 sharesChange Vs. Previous Month+7.44%Dollar Volume Sold Short$121,545.00Short Interest Ratio0.1 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares6,580,000 sharesFloat Size5,440,000 sharesShort Percent of Float4.97%Today's Trading Volume435,514 sharesAverage Trading Volume2,814,569 sharesToday's Volume Vs. Average15% Short Selling Molecular Templates? Sign up to receive the latest short interest report for Molecular Templates and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMTEM Short Interest Over TimeMTEM Days to Cover Over TimeMTEM Percentage of Float Shorted Over Time Ad DTIWhen it comes to NVDA… “acceleration cycles” are the keyExpert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! Molecular Templates Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2024270,100 shares $121,545.00 +7.4%5.0%0.1 $0.45 10/15/2024251,400 shares $84,948.06 +77.2%4.6%0.1 $0.34 9/30/2024141,900 shares $199,369.50 -25.4%2.6%5 $1.41 9/15/2024190,100 shares $226,238.01 +6.0%3.5%6.7 $1.19 8/31/2024179,300 shares $274,329.00 +2.2%3.3%6.1 $1.53 8/15/2024175,500 shares $261,495.00 +42.2%3.2%5 $1.49 Get the Latest News and Ratings for MTEM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Molecular Templates and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024123,400 shares $186,334.00 -5.5%3.0%3.2 $1.51 7/15/2024130,600 shares $184,146.00 +2.0%3.1%3 $1.41 6/30/2024128,000 shares $147,200.00 -30.7%3.1%1.6 $1.15 6/15/2024184,800 shares $241,164.00 -7.7%4.4%2.1 $1.31 5/31/2024200,300 shares $244,366.00 +51.6%5.6%2.3 $1.22 5/15/2024132,100 shares $191,545.00 -21.9%3.7%1.7 $1.45 4/30/2024169,100 shares $277,324.00 -17.8%4.7%2.5 $1.64 4/15/2024205,600 shares $365,968.00 +508.3%7.0%3.3 $1.78 3/31/202433,800 shares $75,712.00 +23.8%1.2%0.6 $2.24 3/15/202427,300 shares $75,075.00 -29.8%0.6%1.8 $2.75 2/29/202438,900 shares $149,765.00 -31.4%0.9%3.6 $3.85 2/15/202456,700 shares $205,254.00 -9.6%1.3%6.3 $3.62 1/31/202462,700 shares $220,077.00 +6.3%1.4%6.7 $3.51 1/15/202459,000 shares $212,400.00 -9.0%1.4%6.2 $3.60 12/31/202364,800 shares $241,704.00 +76.1%1.5%6.8 $3.73 12/15/202336,800 shares $134,688.00 -45.1%0.8%4.2 $3.66 11/30/202367,000 shares $326,960.00 -0.5%1.5%8 $4.88 11/15/202367,300 shares $351,306.00 +2.0%1.5%8.4 $5.22 10/31/202366,000 shares $363,000.00 +11.5%1.5%7.3 $5.50 10/15/202359,200 shares $377,790.72 +1.7%1.4%6.1 $6.38 9/30/202358,200 shares $367,824.00 -6.9%1.3%3.8 $6.32 9/15/202362,500 shares $428,750.00 +9.3%1.4%4.2 $6.86 8/31/202357,200 shares $486,772.00 -39.9%1.3%4 $8.51 8/15/202395,100 shares $789,330.00 -88.3%2.2%6.3 $8.30 7/31/2023809,600 shares $486,569.60 -17.5%N/A3.9 $0.60 7/15/2023981,100 shares $483,682.30 +3.8%N/A5.3 $0.49 6/30/2023945,100 shares $453,648.00 -12.5%2.1%8.3 $0.48 6/15/20231,080,000 shares $539,892.00 +1.9%2.4%7 $0.50 5/31/20231,060,000 shares $498,200.00 +1.9%2.3%1.4 $0.47 5/15/20231,040,000 shares $436,800.00 -14.8%2.3%1.4 $0.42 4/30/20231,220,000 shares $479,338.00 -12.9%2.7%1.6 $0.39 4/15/20231,400,000 shares $658,000.00 +40.0%3.1%1.8 $0.47 3/31/20231,000,000 shares $379,900.00 -5.7%2.3%1.3 $0.38 3/15/20231,060,000 shares $349,906.00 +187.2%2.5%1.4 $0.33When it comes to NVDA… “acceleration cycles” are the key (Ad)Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! 2/28/2023369,100 shares $173,477.00 +27.2%0.9%2.7 $0.47 2/15/2023290,200 shares $139,644.24 -15.9%0.7%1.8 $0.48 1/31/2023345,100 shares $186,008.90 +5.5%0.8%2.1 $0.54 1/15/2023327,200 shares $150,577.44 -6.3%0.7%2.1 $0.46 12/30/2022349,000 shares $114,472.00 -17.7%0.8%2.3 $0.33 12/15/2022423,900 shares $190,755.00 -4.4%1.0%3.2 $0.45 11/30/2022443,500 shares $235,010.65 +3.4%1.0%3.6 $0.53 11/15/2022429,100 shares $272,735.96 -19.6%1.0%4.1 $0.64 10/31/2022533,500 shares $316,952.35 +1.0%1.2%5.4 $0.59 10/15/2022528,100 shares $343,159.38 +7.4%1.3%4.8 $0.65 9/30/2022491,800 shares $368,702.46 -6.9%1.2%4.2 $0.75 9/15/2022528,100 shares $417,938.34 +40.1%1.3%2.5 $0.79 8/31/2022376,900 shares $276,531.53 +18.0%0.9%1.6 $0.73 8/15/2022319,300 shares $309,273.98 +1.5%0.8%1.2 $0.97 7/31/2022314,700 shares $264,977.40 -1.6%0.8%1.1 $0.84 7/15/2022319,800 shares $332,592.00 -32.6%0.8%1 $1.04 6/30/2022474,700 shares $432,736.52 -68.8%1.1%1.4 $0.91 6/15/20221,520,000 shares $1.33 million -2.6%3.6%4.4 $0.87 5/31/20221,560,000 shares $1.54 million +2.0%3.7%6.3 $0.99 5/15/20221,530,000 shares $1.90 million +8.5%3.7%7.2 $1.24 4/30/20221,410,000 shares $2.40 million +24.8%3.4%7.3 $1.70 4/15/20221,130,000 shares $2.86 million +6.6%2.7%6 $2.53 3/31/20221,060,000 shares $3.66 million +2.9%2.5%5.9 $3.45 3/15/20221,030,000 shares $2.42 million +30.9%2.5%4.5 $2.35 2/28/2022786,600 shares $1.85 million +13.1%1.9%3.2 $2.35 2/15/2022695,400 shares $1.93 million +17.2%1.7%2.5 $2.77 1/31/2022593,600 shares $1.83 million +1.3%1.5%2 $3.08 1/15/2022586,200 shares $2.17 million +5.4%1.4%2 $3.70 12/31/2021556,400 shares $2.18 million +2.7%1.3%1.9 $3.92 12/15/2021542,000 shares $1.99 million -11.7%1.3%1.9 $3.67 11/30/2021613,800 shares $2.46 million +1.6%1.5%1.9 $4.01 11/15/2021604,000 shares $3.25 million -9.9%1.5%2 $5.38 10/29/2021670,100 shares $3.50 million -1.0%1.6%2.4 $5.22 10/15/2021676,900 shares $4.29 million -49.1%1.6%2.5 $6.34 9/30/20211,330,000 shares $8.92 million No Change3.2%4.6 $6.71 9/15/20211,330,000 shares $8.07 million +2.3%3.2%5 $6.07 8/31/20211,300,000 shares $8.48 million -16.1%3.2%6.4 $6.52 8/13/20211,550,000 shares $11.78 million -5.5%3.8%7.1 $7.60 7/30/20211,640,000 shares $11.48 million +4.5%4.0%6.9 $7.00 7/15/20211,570,000 shares $10.80 million +0.6%3.9%5.8 $6.88 6/30/20211,560,000 shares $12.20 million +8.3%3.8%4.9 $7.82 6/15/20211,440,000 shares $12.43 million -1.4%3.5%3.4 $8.63 5/28/20211,460,000 shares $13.05 million +4.3%3.6%3.5 $8.94 5/14/20211,400,000 shares $11.68 million -11.4%N/A3.1 $8.34 4/30/20211,580,000 shares $14.79 million -7.1%N/A3.2 $9.36 4/15/20211,700,000 shares $14.03 million +37.1%8.8%3.4 $8.25 3/31/20211,240,000 shares $14.38 million +11.7%N/A2.7 $11.60 3/15/20211,110,000 shares $13.00 million +5.7%N/A3.1 $11.71 2/26/20211,050,000 shares $11.57 million -11.8%N/A2.6 $11.02 2/12/20211,190,000 shares $16.58 million -2.5%N/A2.9 $13.93When it comes to NVDA… “acceleration cycles” are the key (Ad)Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! 1/29/20211,220,000 shares $13.83 million No Change3.4%2.9 $11.34 1/15/20211,220,000 shares $13.53 million -11.6%3.4%2.9 $11.09 12/31/20201,380,000 shares $13.08 million -21.1%3.8%3.5 $9.48 12/15/20201,750,000 shares $17.97 million -14.2%4.8%4.5 $10.27 11/30/20202,040,000 shares $18.60 million +7.4%5.6%5.2 $9.12 11/15/20201,900,000 shares $19.51 million +2.2%5.2%4.9 $10.27 10/30/20201,860,000 shares $17.67 million +14.1%5.1%5.2 $9.50 10/15/20201,630,000 shares $19.19 million +13.2%4.5%5.2 $11.77 9/30/20201,440,000 shares $15.72 million +48.5%4.0%3.6 $10.92 9/15/2020969,500 shares $12.75 million +4.6%2.7%2.2 $13.15 8/31/2020927,300 shares $10.77 million -3.9%2.6%2.3 $11.61 8/14/2020965,000 shares $11.22 million -38.9%2.8%2.3 $11.63 7/31/20201,580,000 shares $17.33 million -3.7%4.6%3.5 $10.97 7/15/20201,640,000 shares $20.02 million +2.5%5.5%3.8 $12.21 6/30/20201,600,000 shares $22.06 million +40.4%5.3%4.5 $13.79 6/15/20201,140,000 shares $17.29 million -5.0%3.8%3.7 $15.17 5/29/20201,200,000 shares $18.52 million -8.4%4.0%4 $15.43 5/15/20201,310,000 shares $21.03 million -6.4%4.5%4.5 $16.05 4/30/20201,400,000 shares $23.70 million -4.8%4.6%5.3 $16.93 4/15/20201,470,000 shares $23.28 million -13.5%5.3%5.3 $15.84 3/31/20201,700,000 shares $28.90 million -5.9%6.1%5.8 $17.00 3/13/20201,806,900 shares $27.21 million +39.0%7.0%6.7 $15.06 2/28/20201,300,000 shares $16.03 million +9.2%5.0%3.8 $12.33 2/14/20201,190,000 shares $17.49 million No Change5.9%3.1 $14.70 1/31/20201,190,000 shares $19.56 million -3.3%5.9%3.1 $16.44 1/15/20201,230,000 shares $18.81 million -2.4%5.6%3.4 $15.29 12/31/20191,260,000 shares $17.07 million +10.5%5.7%3.6 $13.55 MTEM Short Interest - Frequently Asked Questions What is Molecular Templates' current short interest? Short interest is the volume of Molecular Templates shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 270,100 shares of MTEM short. 4.97% of Molecular Templates' shares are currently sold short. Learn More on Molecular Templates' current short interest. What is a good short interest percentage for Molecular Templates? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.97% of Molecular Templates' floating shares are currently sold short. Is Molecular Templates' short interest increasing or decreasing? Molecular Templates saw a increase in short interest in October. As of October 31st, there was short interest totaling 270,100 shares, an increase of 7.4% from the previous total of 251,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Molecular Templates' float size? Molecular Templates currently has issued a total of 6,580,000 shares. Some of Molecular Templates' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Molecular Templates currently has a public float of 5,440,000 shares. How does Molecular Templates' short interest compare to its competitors? 4.97% of Molecular Templates' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Molecular Templates: Cogent Biosciences, Inc. (7.63%), Wave Life Sciences Ltd. (4.47%), Bristol-Myers Squibb (1.15%), Sanofi (0.32%), Amgen Inc. (1.64%), Vertex Pharmaceuticals Incorporated (1.75%), Gilead Sciences, Inc. (1.43%), Regeneron Pharmaceuticals, Inc. (1.68%), Alnylam Pharmaceuticals, Inc. (2.87%), Biogen Inc. (2.16%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Molecular Templates stock? Short selling MTEM is an investing strategy that aims to generate trading profit from Molecular Templates as its price is falling. MTEM shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Molecular Templates? A short squeeze for Molecular Templates occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MTEM, which in turn drives the price of the stock up even further. How often is Molecular Templates' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MTEM, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Cogent Biosciences Short Squeeze Wave Life Sciences Short Squeeze Bristol-Myers Squibb Short Squeeze Sanofi Short Squeeze Amgen Short Squeeze Vertex Pharmaceuticals Short Squeeze Gilead Sciences Short Squeeze Regeneron Pharmaceuticals Short Squeeze Alnylam Pharmaceuticals Short Squeeze Biogen Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MTEM) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Molecular Templates, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Molecular Templates With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
